Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Comment by GJS471on Mar 09, 2023 10:01am
270 Views
Post# 35327925

RE:CPH: Outperformer, Give Credit When Credit Is Due

RE:CPH: Outperformer, Give Credit When Credit Is Due
As we approach another quarterly earnings announcement, I just wanted to say that as a long time investor, my numbers are not yours.  It has been what I classify as a "faith" investment from several years ago.  I thought the Sr. Mull knew what he was doing.  It apperas he did not from an earnings and stock price perspectiive from the history of stock prices.. 
But I drank the coolaid  many years ago at a much higher cost than you  have.  I stayed in because there was so little down side.   But I am wary of new promises.  Results count.  And it has been  bleak for some time.  
I hope good reulsts for everyone this time round. 
<< Previous
Bullboard Posts
Next >>